{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:09:35Z","timestamp":1792030175208,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00203-024-03894-9","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T22:01:51Z","timestamp":1710280911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["3-bromopyruvate induces morphological alteration and may initiate programmed cell death in Cryptococcus neoformans cells"],"prefix":"10.1007","volume":"206","author":[{"given":"Katarzyna","family":"Przywara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ksi\u0105\u017cczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Suchodolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"3894_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/s0006-291x(03)00479-0","volume":"303","author":"JH Bae","year":"2003","unstructured":"Bae JH, Park JW, Kwon TK (2003) Ruthenium red, inhibitor of mitochondrial Ca 2+ uniporter, inhibits curcumin-induced apoptosis via the prevention of intracellular Ca 2+ depletion and cytochrome c release. Biochem Biophys Res Commun 303:1073\u20131079. https:\/\/doi.org\/10.1016\/s0006-291x(03)00479-0","journal-title":"Biochem Biophys Res Commun"},{"key":"3894_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","volume":"173","author":"B Bhattacharya","year":"2016","unstructured":"Bhattacharya B, Mohd Omar MF, Soong R (2016) The Warburg effect and drug resistance. Br J Pharmacol 173:970\u2013979. https:\/\/doi.org\/10.1111\/bph.13422","journal-title":"Br J Pharmacol"},{"key":"3894_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/02841860902974175","volume":"48","author":"C Burz","year":"2009","unstructured":"Burz C, Berindan-Neagoe I, Balacescu O, Irimie A (2009) Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48:811\u2013821. https:\/\/doi.org\/10.1080\/02841860902974175","journal-title":"Acta Oncol"},{"key":"3894_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/cells9051161","volume":"9","author":"M Cal","year":"2020","unstructured":"Cal M, Matyjaszczyk I, Litwin I, Augustyniak D, Og\u00f3rek R, Ko Y, U\u0142aszewski S (2020) The anticancer drug 3-bromopyruvate induces DNA damage potentially through reactive oxygen species in yeast and in human cancer cells. Cells 9:1161. https:\/\/doi.org\/10.3390\/cells9051161","journal-title":"Cells"},{"key":"3894_CR5","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.3390\/ijms22126640","volume":"22","author":"M Cal","year":"2021","unstructured":"Cal M, Matyjaszczyk I, Filik K, Og\u00f3rek R, Ko Y, U\u0142aszewski S (2021) Mitochondrial function are disturbed in the presence of the anticancer drug, 3-bromopyruvate. Int J Mol Sci 22:6640. https:\/\/doi.org\/10.3390\/ijms22126640","journal-title":"Int J Mol Sci"},{"key":"3894_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1124\/jpet.113.206714","volume":"348","author":"E Calvi\u00f1o","year":"2014","unstructured":"Calvi\u00f1o E, Esta\u00f1 MC, S\u00e1nchez-Mart\u00edn C, Brea R, de Blas E, Boyano-Ad\u00e1nez Mdel C, Rial E, Aller P (2014) Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation. J Pharmacol Exp Ther 348:324\u2013335. https:\/\/doi.org\/10.1124\/jpet.113.206714","journal-title":"J Pharmacol Exp Ther"},{"key":"3894_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","volume":"2","author":"RD Cannon","year":"2009","unstructured":"Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2:291\u2013321. https:\/\/doi.org\/10.1128\/CMR.00051-08","journal-title":"Clin Microbiol Rev"},{"key":"3894_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/genetics\/80.1.23","volume":"80","author":"MR Culbertson","year":"1975","unstructured":"Culbertson MR, Henry SA (1975) Inositol-requiring mutants of Saccharomyces cerevisiae. Genetics 80:23\u201340. https:\/\/doi.org\/10.1093\/genetics\/80.1.23","journal-title":"Genetics"},{"key":"3894_CR9","doi-asserted-by":"publisher","first-page":"14343","DOI":"10.1038\/srep14343","volume":"5","author":"M Davidescu","year":"2015","unstructured":"Davidescu M, Macchioni L, Scaramozzino G, Cristina Marchetti M, Migliorati G, Vitale R, Corcelli A, Roberti R, Castigli E, Corazzi L (2015) The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes. Scientific Rep 5:14343. https:\/\/doi.org\/10.1038\/srep14343","journal-title":"Scientific Rep"},{"key":"3894_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11046-011-9473-z","volume":"173","author":"M Del Poeta","year":"2012","unstructured":"Del Poeta M, Casadevall A (2012) Ten challenges on Cryptococcus and cryptococcosis. Mycopathologia 173:303\u2013310. https:\/\/doi.org\/10.1007\/s11046-011-9473-z","journal-title":"Mycopathologia"},{"key":"3894_CR11","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.lfs.2006.06.043","volume":"79","author":"P Dell\u2019Antone","year":"2006","unstructured":"Dell\u2019Antone P (2006) Inactivation of H + -vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent. Life Sci 79:2049\u20132055. https:\/\/doi.org\/10.1016\/j.lfs.2006.06.043","journal-title":"Life Sci"},{"key":"3894_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbrc.2013.02.125","volume":"434","author":"M Dyl\u0105g","year":"2013","unstructured":"Dyl\u0105g M, Lis P, Nied\u017awiecka K, Ko YH, Pedersen PL, Goffeau A, U\u0142aszewski S (2013) 3-bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans. Biochem Biophys Res Commun 434:322\u2013327. https:\/\/doi.org\/10.1016\/j.bbrc.2013.02.125","journal-title":"Biochem Biophys Res Commun"},{"key":"3894_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2012.00064","volume":"2","author":"G Farrugia","year":"2012","unstructured":"Farrugia G, Balzan R (2012) Oxidative stress and programmed cell death in yeast. Front Oncol 2:1\u201321. https:\/\/doi.org\/10.3389\/fonc.2012.00064","journal-title":"Front Oncol"},{"key":"3894_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1128\/EC.00245-10","volume":"10","author":"JS Fassler","year":"2011","unstructured":"Fassler JS, West AH (2011) Fungal Skn7 stress responses and their relationship to virulence. Eukaryot Cell 10:156\u2013167. https:\/\/doi.org\/10.1128\/EC.00245-10","journal-title":"Eukaryot Cell"},{"key":"3894_CR15","first-page":"13","volume":"33","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Kunjithapatham R, Geschwind JF (2013) Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting. Anticancer Res 33:13\u201320","journal-title":"Anticancer Res"},{"key":"3894_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bcp.2014.07.027","volume":"92","author":"N Guaragnella","year":"2014","unstructured":"Guaragnella N, Giannattasio S, Moro L (2014) Mitochondrial dysfunction in cancer chemoresistance. Biochem Pharmacol 92:62\u201372. https:\/\/doi.org\/10.1016\/j.bcp.2014.07.027","journal-title":"Biochem Pharmacol"},{"key":"3894_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/biof.5520170111","volume":"17","author":"L Homolya","year":"2003","unstructured":"Homolya L, V\u00e1radi A, Sarkadi B (2003) Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate. BioFactors 17:103\u2013114. https:\/\/doi.org\/10.1002\/biof.5520170111","journal-title":"BioFactors"},{"key":"3894_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fphar.2018.00375","volume":"9","author":"T Jagielski","year":"2018","unstructured":"Jagielski T, Nied\u017awiecka K, Roeske K, Dylag M (2018) 3-Bromopyruvate as an alternative option for the treatment of protothecosis. Front Pharmacol 9:375. https:\/\/doi.org\/10.3389\/fphar.2018.00375","journal-title":"Front Pharmacol"},{"key":"3894_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10863-008-9188-0","volume":"40","author":"JS Kim","year":"2008","unstructured":"Kim JS, Ahn KJ, Kim JA, Kim HM, Lee JD, Lee JM, Kim SJ, Park JH (2008) Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells\u202f: RROS-mediated cell death by 3-BrPA. J Bioenerg Biomembr 40:607\u2013618. https:\/\/doi.org\/10.1007\/s10863-008-9188-0","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbrc.2004.09.047","volume":"324","author":"YH Ko","year":"2004","unstructured":"Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL (2004) Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 324:269\u2013275. https:\/\/doi.org\/10.1016\/j.bbrc.2004.09.047","journal-title":"Biochem Biophys Res Commun"},{"key":"3894_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10863-012-9417-4","volume":"44","author":"YH Ko","year":"2012","unstructured":"Ko YH, Verhoeven HA, Lee MJ, Corbin DJ, Vogl TJ, Pedersen PL (2012) A translational study \u201ccase report\u201d on the small molecule \u201cenergy blocker\u201d 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside. J Bioenerg Biomembr 44:163\u2013170. https:\/\/doi.org\/10.1007\/s10863-012-9417-4","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10863-015-9637-5","volume":"48","author":"E Kwiatkowska","year":"2016","unstructured":"Kwiatkowska E, Wojtala M, Gajewska A, Soszy\u0144ski M, Bartosz G, Sadowska-Bartosz I (2016) Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells. J Bioenerg Biomembr 48:23\u201332. https:\/\/doi.org\/10.1007\/s10863-015-9637-5","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019760","volume":"4","author":"KJ Kwon-Chung","year":"2014","unstructured":"Kwon-Chung KJ, Fraser JA, Doering TL, Wang ZA, Janbon G, Idnurm A, Bahn Y (2014) Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med 4:a019760. https:\/\/doi.org\/10.1101\/cshperspect.a019760","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3894_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/molecules21121730","volume":"21","author":"P Lis","year":"2016","unstructured":"Lis P, Dyl\u0105g M, Nied\u017awiecka K, Ko YH, Pedersen PL, Goffeau A, U\u0142aszewski S (2016a) The HK2 dependent \u201cwarburg effect\u201d and mitochondrial oxidative phosphorylation in cancer: targets for effective therapy with 3-bromopyruvate. Molecules 21:1730. https:\/\/doi.org\/10.3390\/molecules21121730","journal-title":"Molecules"},{"key":"3894_CR25","doi-asserted-by":"publisher","first-page":"10153","DOI":"10.18632\/oncotarget.7174","volume":"7","author":"P Lis","year":"2016","unstructured":"Lis P, Jurkiewicz P, Cal-B\u0105kowska M, Ko YH, Pedersen PL, Goffeau A, U\u0142aszewski S (2016b) Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate. Oncotarget 7:10153\u201310173. https:\/\/doi.org\/10.18632\/oncotarget.7174","journal-title":"Oncotarget"},{"key":"3894_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/CAD.0000000000000094","volume":"25","author":"G Majkowska-Skrobek","year":"2014","unstructured":"Majkowska-Skrobek G, Augustyniak D, Lis P, Bartkowiak A, Gonchar M, Ko YH, Pedersen PL, Goffeau A, U\u0142aszewski S (2014) Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy. Anticancer Drugs 25:673\u2013682. https:\/\/doi.org\/10.1097\/CAD.0000000000000094","journal-title":"Anticancer Drugs"},{"key":"3894_CR27","doi-asserted-by":"publisher","first-page":"65614","DOI":"10.18632\/oncotarget.11592","volume":"7","author":"K Nied\u017awiecka","year":"2016","unstructured":"Nied\u017awiecka K, Dyl\u0105g M, Augustyniak D, Majkowska-Skrobek G, Cal-B\u0105kowska M, Ko YH, Pedersen PL, Goffeau A, U\u0142aszewski S (2016) Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma. Oncotarget 7:65614\u201365626. https:\/\/doi.org\/10.18632\/oncotarget.11592","journal-title":"Oncotarget"},{"key":"3894_CR28","doi-asserted-by":"publisher","first-page":"foz029","DOI":"10.1093\/femsyr\/foz029","volume":"19","author":"K Nied\u017awiecka","year":"2019","unstructured":"Nied\u017awiecka K, Ribas D, Casal M, U\u0142aszewski S (2019) The Cryptococcus neoformans monocarboxylate transporter Jen4 is responsible for increased 3-bromopyruvate sensitivity. FEMS Yeast Res 19:foz029. https:\/\/doi.org\/10.1093\/femsyr\/foz029","journal-title":"FEMS Yeast Res"},{"key":"3894_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10863-012-9470-z","volume":"44","author":"PL Pedersen","year":"2012","unstructured":"Pedersen PL (2012a) Mitochondria in relation to cancer metastasis: Introduction to a mini-review series. J Bioenerg Biomembr 44:615\u2013617. https:\/\/doi.org\/10.1007\/s10863-012-9470-z","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10863-012-9425-4","volume":"44","author":"PL Pedersen","year":"2012","unstructured":"Pedersen PL (2012b) 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective \u201csmall molecule\u201d anti-cancer agent taken from labside to bedside: introduction to a special issue. J Bioenerg Biomembr 44:1\u20136. https:\/\/doi.org\/10.1007\/s10863-012-9425-4","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/BJ20080805","volume":"417","author":"A Pereira da Silva","year":"2009","unstructured":"Pereira da Silva A, El-Bacha T, Kyaw N, dos Santos R, da Silva W, Almeida FC, da Poian A, Galina A (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J 417:717\u2013726. https:\/\/doi.org\/10.1042\/BJ20080805","journal-title":"Biochem J"},{"key":"3894_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10495-005-6075-6","volume":"10","author":"S Rello","year":"2005","unstructured":"Rello S, Stockert JC, Moreno V, G\u00e1mez A, Pacheco M, Juarranz A, Ca\u00f1ete M, Villanueva A (2005) Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 10:201\u2013208. https:\/\/doi.org\/10.1007\/s10495-005-6075-6","journal-title":"Apoptosis"},{"key":"3894_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1083\/jcb.17.1.208","volume":"17","author":"ES Reynolds","year":"1963","unstructured":"Reynolds ES (1963) The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208\u2013212. https:\/\/doi.org\/10.1083\/jcb.17.1.208","journal-title":"J Cell Biol"},{"key":"3894_CR34","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/cbin.10160","volume":"37","author":"I Sadowska-Bartosz","year":"2013","unstructured":"Sadowska-Bartosz I, Bartosz G (2013) Effect of 3-bromopyruvic acid on human erythrocyte antioxidant defense system. Cell Biol Int 37:1285\u20131290. https:\/\/doi.org\/10.1002\/cbin.10160","journal-title":"Cell Biol Int"},{"key":"3894_CR35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","volume":"9","author":"D Sanglard","year":"2009","unstructured":"Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9:1029\u20131050. https:\/\/doi.org\/10.1111\/j.1567-1364.2009.00578.x","journal-title":"FEMS Yeast Res"},{"key":"3894_CR36","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1093\/nar\/18.10.3091","volume":"18","author":"ME Schmitt","year":"1990","unstructured":"Schmitt ME, Brown TA, Trumpower BL (1990) A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res 18:3091\u20133092. https:\/\/doi.org\/10.1093\/nar\/18.10.3091","journal-title":"Nucleic Acids Res"},{"key":"3894_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10863-012-9419-2","volume":"44","author":"MC Shoshan","year":"2012","unstructured":"Shoshan MC (2012) 3-bromopyruvate: targets and outcomes. J Bioenerg Biomembr 44:7\u201315. https:\/\/doi.org\/10.1007\/s10863-012-9419-2","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0005-2744(67)90059-9","volume":"139","author":"M Staub","year":"1967","unstructured":"Staub M, Denese G (1967) A kinetic study on the inactivation of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase by bromopyruvate. Biochem Biophys Acta 139:519\u2013521. https:\/\/doi.org\/10.1016\/0005-2744(67)90059-9","journal-title":"Biochem Biophys Acta"},{"key":"3894_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/fgbi.1999.1126","volume":"27","author":"S Sudarshan","year":"1999","unstructured":"Sudarshan S, Davidson RC, Heitman J, Alspaugh JA (1999) Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption. Fungal Genet Biol 27:36\u201348. https:\/\/doi.org\/10.1006\/fgbi.1999.1126","journal-title":"Fungal Genet Biol"},{"key":"3894_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10863-015-9612-1","volume":"47","author":"Y Sun","year":"2015","unstructured":"Sun Y, Liu Z, Zou X, Lan Y, Sun X (2015) Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer. J Bioenerg Biomembr 47:319\u2013329. https:\/\/doi.org\/10.1007\/s10863-015-9612-1","journal-title":"J Bioenerg Biomembr"},{"key":"3894_CR41","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1002\/cncr.24532","volume":"115","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M, Karunakaran S, Itagaki S, Gopal E, Elangovan S, Prasad P, Ganapathy V (2009) Transport via SLC5A8 with subsequent inhibition of histone deacetylases HDAC1 and HDAC3 underlies the antitumor activity of 3-bromopyruvate. Cancer 115:4655\u20134666. https:\/\/doi.org\/10.1002\/cncr.24532","journal-title":"Cancer"},{"key":"3894_CR42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3892\/or.2015.4511","volume":"35","author":"T Wang","year":"2016","unstructured":"Wang T, Zhang X, Guo X, Xian S, Lu Y (2016) 3-Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth. Oncol Rep 35:1287\u20131296. https:\/\/doi.org\/10.3892\/or.2015.4511","journal-title":"Oncol Rep"},{"key":"3894_CR43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.18632\/genesandcancer.9","volume":"5","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Zhang Y, Zhang P, Chao Z, Xia F, Jiang C, Zhang X, Jiang Z, Liu H (2014) Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells. Genes Cancer 5:100\u2013112. https:\/\/doi.org\/10.18632\/genesandcancer.9","journal-title":"Genes Cancer"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-03894-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-024-03894-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-03894-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T10:50:54Z","timestamp":1713351054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-024-03894-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3894"],"URL":"https:\/\/doi.org\/10.1007\/s00203-024-03894-9","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}